Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives
- 1 September 2013
- journal article
- review article
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 1 (1) , 59-70
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolismJournal of Clinical Investigation, 2012
- Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?Osteoporosis International, 2012
- Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cellsProceedings of the National Academy of Sciences, 2011
- Matrix-embedded cells control osteoclast formationNature Medicine, 2011
- Col3.6-HSD2 transgenic mice: A glucocorticoid loss-of-function model spanning early and late osteoblast differentiationBone, 2010
- Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone lossAnnals of the Rheumatic Diseases, 2010
- Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalkJournal of Bone and Mineral Research, 2010
- Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged miceAging Cell, 2010
- Glucocorticoid Regulation of Mouse and Human Dual Specificity Phosphatase 1 (DUSP1) GenesJournal of Biological Chemistry, 2010
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007